Journal
Epidemiology
Clinical Information and Management
Vaccination
- Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis (January 29, 2020)
- Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, et al. Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older. The Journals of Gerontology: Series A. 2018 Jun 27.
- Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older. (2018 Feb 26).
- Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine. (2018 Jul 9).
- Cost-effectiveness of the Adjuvanted herpes zoster subunit vaccine in older adults. (2018 Feb 1).
- Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older.(2016 Sep 15)
Local Research